Literature DB >> 11074418

Tissue engineering: challenges and opportunities.

M S Chapekar1.   

Abstract

This article reviews the key developments in the tissue engineering field over the past several years. The issues related to the development of the components of tissue-engineered products including cells, biomaterials, and biomolecules, and their integration into safe and effective products are presented. Moreover, the article outlines the challenges to the commercialization of tissue-engineered products, and highlights the ongoing efforts by the American Society for Testing and Materials (ASTM) in developing standards for tissue-engineered medical products. Furthermore, funding opportunities at the Advanced Technology Program at NIST are presented. Published 2000 John Wiley & Sons, Inc.

Mesh:

Substances:

Year:  2000        PMID: 11074418     DOI: 10.1002/1097-4636(2000)53:6<617::aid-jbm1>3.0.co;2-c

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  21 in total

1.  Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation.

Authors:  Fengfu Li; David Carlsson; Chris Lohmann; Erik Suuronen; Sandy Vascotto; Karin Kobuch; Heather Sheardown; Rejean Munger; Masatsugu Nakamura; May Griffith
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

Review 2.  Getting to the heart of tissue engineering.

Authors:  Luda Khait; Louise Hecker; Nicole R Blan; Garrett Coyan; Francesco Migneco; Yen-Chih Huang; Ravi K Birla
Journal:  J Cardiovasc Transl Res       Date:  2008-01-29       Impact factor: 4.132

Review 3.  [Bridging posttraumatic bony defects. Established and new methods].

Authors:  M Schieker; W Mutschler
Journal:  Unfallchirurg       Date:  2006-09       Impact factor: 1.000

4.  Positive selection for bone morphogenetic protein receptor type-IB promotes differentiation and specification of human adipose-derived stromal cells toward an osteogenic lineage.

Authors:  Adrian McArdle; Michael T Chung; Kevin J Paik; Chris Duldulao; Charles Chan; Robert Rennert; Graham G Walmsley; Kshemendra Senarath-Yapa; Michael Hu; Elly Seo; Min Lee; Derrick C Wan; Michael T Longaker
Journal:  Tissue Eng Part A       Date:  2014-06-30       Impact factor: 3.845

5.  Rapid Isolation of BMPR-IB+ Adipose-Derived Stromal Cells for Use in a Calvarial Defect Healing Model.

Authors:  Clement D Marshall; Elizabeth R Zielins; Elizabeth A Brett; Charles P Blackshear; Michael S Hu; Tripp Leavitt; Leandra A Barnes; H Peter Lorenz; Michael T Longaker; Derrick C Wan
Journal:  J Vis Exp       Date:  2017-02-24       Impact factor: 1.355

Review 6.  Nanomaterials, inflammation, and tissue engineering.

Authors:  Jagannath Padmanabhan; Themis R Kyriakides
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-11-25

7.  Small-diameter artery decellularization: Effects of anionic detergent concentration and treatment duration on porcine internal thoracic arteries.

Authors:  Colton Kostelnik; Julia Hohn; Carlos E Escoto-Diaz; Jesse B Kooistra; Matthew Stern; Derrick E Swinton; William Richardson; Wayne Carver; John Eberth
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2021-12-02       Impact factor: 3.368

8.  Avian Egg: A Multifaceted Biomaterial for Tissue Engineering.

Authors:  Shahriar Mahdavi; Armin Amirsadeghi; Arman Jafari; Seyyed Vahid Niknezhad; Sidi A Bencherif
Journal:  Ind Eng Chem Res       Date:  2021-11-23       Impact factor: 3.720

9.  Effect of streptomycin on the active force of bioengineered heart muscle in response to controlled stretch.

Authors:  R K Birla; Y C Huang; R G Dennis
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-06-21       Impact factor: 2.416

10.  Magnetic poly(ε-caprolactone)/iron-doped hydroxyapatite nanocomposite substrates for advanced bone tissue engineering.

Authors:  A Gloria; T Russo; U D'Amora; S Zeppetelli; T D'Alessandro; M Sandri; M Bañobre-López; Y Piñeiro-Redondo; M Uhlarz; A Tampieri; J Rivas; T Herrmannsdörfer; V A Dediu; L Ambrosio; R De Santis
Journal:  J R Soc Interface       Date:  2013-01-09       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.